Viewing Study NCT06121505


Ignite Creation Date: 2025-12-25 @ 3:24 AM
Ignite Modification Date: 2026-03-03 @ 11:12 AM
Study NCT ID: NCT06121505
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2023-10-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer
Sponsor: Sichuan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None SBRT View
None Immunotherapy View
None LDRT View
None Lung Squamous Cell Carcinoma View